Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Convertible Debt (2022)

Coya Therapeutics' Convertible Debt history spans 1 years, with the latest figure at $13.0 million for Q4 2022.

  • For Q4 2022, Convertible Debt changed N/A year-over-year to $13.0 million; the TTM value through Dec 2022 reached $13.0 million, changed N/A, while the annual FY2022 figure was $13.0 million, N/A changed from the prior year.
  • Convertible Debt for Q4 2022 was $13.0 million at Coya Therapeutics.
  • Across five years, Convertible Debt topped out at $13.0 million in Q4 2022 and bottomed at $13.0 million in Q4 2022.